These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26595160)

  • 1. Summaries for Patients. Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications.
    Ann Intern Med; 2016 Jan; 164(1):. PubMed ID: 26595160
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians.
    Choudhry NK; Denberg TD; Qaseem A;
    Ann Intern Med; 2016 Jan; 164(1):41-9. PubMed ID: 26594818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic clopidogrel: time to substitute?
    Doll J; Zeitler E; Becker R
    JAMA; 2013 Jul; 310(2):145-6. PubMed ID: 23839745
    [No Abstract]   [Full Text] [Related]  

  • 4. Lessons learned in Reno.
    Contillo C
    Am J Nurs; 2011 Jan; 111(1):11. PubMed ID: 21191208
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-31. PubMed ID: 29361657
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications.
    Clark B; DuChane J; Hou J; Rubinstein E; McMurray J; Duncan I
    J Manag Care Pharm; 2014 Feb; 20(2):141-50. PubMed ID: 24456315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
    Patel RA; Walberg MP; Tong E; Tan F; Rummel AE; Woelfel JA; Carr-Lopez SM; Galal SM
    J Manag Care Spec Pharm; 2014 Mar; 20(3):283-90. PubMed ID: 24564812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic drugs in dermatology: part II.
    Payette M; Grant-Kels JM
    J Am Acad Dermatol; 2012 Mar; 66(3):353.e1-15; quiz 367-8. PubMed ID: 22342022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries?
.
    Cattaneo D; Andreoni M; Carosi G; Cauda R; Lazzarin A; Rizzardini G
    Int J Clin Pharmacol Ther; 2017 May; 55(5):381-393. PubMed ID: 28211784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic drug products in paediatrics: Where are the data?
    Illamola SM; Birnbaum AK; Sherwin CM
    Br J Clin Pharmacol; 2019 Sep; 85(9):1871-1873. PubMed ID: 31281980
    [No Abstract]   [Full Text] [Related]  

  • 11. Generic drugs versus brand names: switching could save money. Generic drugs have to go through the same FDA approvals as brand names, so they have the same quality.
    Harv Womens Health Watch; 2013 Jul; 20(11):3. PubMed ID: 24818274
    [No Abstract]   [Full Text] [Related]  

  • 12. Reducing the burden of medication costs to improve medication adherence.
    Shaw CR
    Nurse Pract; 2014 Jul; 39(7):43-7. PubMed ID: 24932794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
    Grice S
    N Z Bioeth J; 2003 Oct; 4(3):22-4. PubMed ID: 15597479
    [No Abstract]   [Full Text] [Related]  

  • 14. When is a "generic" medication not really a generic?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Feb; 48(2):13-6. PubMed ID: 20166651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State Medicaid programs missed $220 million in uncaptured savings as generic fluoxetine came to market, 2001-05.
    Kelton CM; Chang LV; Kreling DH
    Health Aff (Millwood); 2013 Jul; 32(7):1204-11. PubMed ID: 23836735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals and medical devices: cost savings.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceutical step-therapy interventions: a critical review of the literature.
    Motheral BR
    J Manag Care Pharm; 2011 Mar; 17(2):143-55. PubMed ID: 21348547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encouraging generic use can yield significant savings.
    Zimmerman C
    Find Brief; 2012 Nov; 15(8):1-3. PubMed ID: 23213854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How the FDA Ensures High-Quality Generic Drugs.
    Uhl K; Peters JR
    Am Fam Physician; 2018 Jun; 97(11):696-697. PubMed ID: 30215932
    [No Abstract]   [Full Text] [Related]  

  • 20. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
    Woolner D
    N Z Bioeth J; 2003 Oct; 4(3):22, 25-6. PubMed ID: 15597481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.